STRATA Skin Sciences Cash Flow - Quarterly (NASDAQ:SSKN)

Add to My Stocks
$2.17 $0.02 (0.93%) SSKN stock closing price Jun 22, 2018 (Closing)

The financial analysis of SSKN requires an investor to check the cash flows for STRATA Skin Sciences. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about STRATA Skin Sciences profits and STRATA Skin Sciences debt. STRATA Skin Sciences saw a cash impact of $- from the buyback of SSKN shares. The cash flow statement helps in the STRATA Skin Sciences stock analysis by providing more information for evaluating changes in assets, liabilities and equities. STRATA Skin Sciences had an outflow of $- from operating activities, $-0.3M spend due to financing activities, and $-0.4M outflow due to investing activities till 2018 Q1.

View and download details of STRATA Skin Sciences cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-2.22M-18.83M-17.11M-3.44M-2.23M-3.33M-2.44M-0.93M-1.43M-24.94M
Depreciation Depletion Amortization Cash-Flow1.45M8.88M7.32M4.94M2.32M9.03M6.81M4.65M2.37M12.92M
Net Increase (Decrease) in Assets Liabilities-1.36M-0.04M-0.02M--0.58M-0.92M-0.71M-0.61M-0.37M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net-12.72M12.07M---4.79M-4.52M-4.56M-1.71M5.81M
Net Cash from (used by) Operating Activities
-4.14M2.24M1.69M---1.08M-1.57M-1.39M-6.58M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.32M-0.32M-0.2M-0.2M-----0.03M
Acquisition Disposition of Subsidiaires----------42.5M
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities-0.39M-1.87M-1.56M-1.28M-0.68M-0.99M-0.46M-0.18M-0.18M-1.68M
Net Cash from (used by) Investment Activities
-0.4M-2.19M-1.88M-1.48M-0.88M-0.86M-0.46M-0.18M-0.18M-44.22M
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities-0.1M-1.42M-0.85M-0.2M-0.1M1.5M1.5M1.5M1.5M42.89M
Increase (Decrease) in Bank & Other Borrowings--0.37M-0.3M---0.33M-0.29M-0.2M-0.1M-0.09M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.2M---------0.13M
Net Cash from (used by) Financing Activities
-0.3M-1.8M-1.16M-0.2M-0.1M1.16M1.2M1.29M1.39M42.67M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-0.65M--0.8M--0.16M--0.34M-0.46M-0.18M-8.13M
Cash & Equivalents at Beginning of Year3.92M3.3M11.43M3.78M7.86M27.99M30.52M29.67M15.06M19.19M
Cash & Equivalents at Year End3.41M4.06M3.12M3.93M3.76M3.92M2.95M2.84M3.12M3.3M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

STRATA Skin Sciences stock comparison chart provides an easy way to compare the stock price with peers along with details of STRATA Skin Sciences stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that STRATA Skin Sciences is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - STRATA Skin Sciences stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $- for SSKN.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.4M for SSKN till last quarter 2018 Q1 report.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. STRATA Skin Sciences spent $-0.3M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For STRATA Skin Sciences Cash Flow

FCF margin
0.01